The effect of tocilizumab on mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials

被引：0
|
作者：
Chia Siang Kow
Syed Shahzad Hasan
机构：
[1] International Medical University,School of Postgraduate Studies
[2] University of Huddersfield,School of Applied Sciences
[3] University of Newcastle,School of Biomedical Sciences & Pharmacy
来源：
European Journal of Clinical Pharmacology | 2021年 / 77卷
关键词：
Bias; Clinical trial; COVID-19; Mortality; Tocilizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1089 / 1094
页数：5
相关论文
共 50 条
  • [1] The effect of tocilizumab on mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials
    Kow, Chia Siang
    Hasan, Syed Shahzad
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (08) : 1089 - 1094
  • [2] Tocilizumab in Hospitalized Patients with COVID-19: A Meta Analysis of Randomized Controlled Trials
    Vijairam Selvaraj
    Mohammad Saud Khan
    Chirag Bavishi
    Kwame Dapaah-Afriyie
    Arkadiy Finn
    Amos Lal
    Eleftherios Mylonakis
    Lung, 2021, 199 : 239 - 248
  • [3] Tocilizumab in Hospitalized Patients with COVID-19: A Meta Analysis of Randomized Controlled Trials
    Selvaraj, Vijairam
    Khan, Mohammad Saud
    Bavishi, Chirag
    Dapaah-Afriyie, Kwame
    Finn, Arkadiy
    Lal, Amos
    Mylonakis, Eleftherios
    LUNG, 2021, 199 (03) : 239 - 248
  • [4] Tocilizumab in patients hospitalized with COVID-19 pneumonia: systematic review and meta-analysis of randomized controlled trials
    Gupta, Samiksha
    Padappayil, Rana Prathap
    Bansal, Agam
    Daouk, Salim
    Brown, Brent
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (01) : 55 - 60
  • [5] The effect of tocilizumab on COVID-19 patient mortality: A systematic review and meta-analysis of randomized controlled trials
    Lin, Wei-Ting
    Hung, Shun-Hsing
    Lai, Chih-Cheng
    Wang, Cheng-Yi
    Chen, Chao-Hsien
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 96
  • [6] BARICITINIB IN HOSPITALIZED PATIENTS WITH COVID-19: META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Selvaraj, Vijairam
    Finn, Arkadiy
    Lal, Amos
    Carino, Gerardo P.
    CHEST, 2022, 162 (04) : 972A - 972A
  • [7] FAVIPIRAVIR IN HOSPITALIZED COVID-19 PATIENTS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Naveed, Aiman
    Cheema, Huzaifa
    Shahid, Abia
    Singh, Harpreet
    Kurman, Jonathan
    Rehman, Mohammad Ebad Ur
    Umer, Mohammad
    Sahra, Syeda
    Ahmad, Faran
    Ahmad, Sharjeel
    CRITICAL CARE MEDICINE, 2024, 52
  • [8] Effect of intravenous immunoglobulin on mortality in hospitalized patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials
    Ramachandram, Dinesh Sangarran
    Kow, Chia Siang
    Hasan, Syed Shahzad
    Thiruchelvam, Kaeshaelya
    HEALTH SCIENCE REPORTS, 2024, 7 (07)
  • [9] Tocilizumab for COVID-19: A systematic review and meta-analysis of randomized controlled trials
    Boppana, Tarun Krishna
    Mittal, Saurabh
    Madan, Karan
    Mohan, Anant
    Hadda, Vijay
    Guleria, Randeep
    MONALDI ARCHIVES FOR CHEST DISEASE, 2022, 92 (04)
  • [10] Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials
    Siempos, Ilias I.
    Kalil, Andre C.
    Belhadi, Drifa
    Veiga, Viviane Cordeiro
    Cavalcanti, Alexandre Biasi
    Branch-Elliman, Westyn
    Papoutsi, Eleni
    Gkirgkiris, Konstantinos
    Xixi, Nikoleta A.
    Kotanidou, Anastasia
    Hermine, Olivier
    Porcher, Raphael
    Mariette, Xavier
    ECLINICALMEDICINE, 2024, 69
12345